We are live on ! Find out more
IDXX icon

Idexx Laboratories

1,059 hedge funds and large institutions have $32.4B invested in Idexx Laboratories in 2023 Q3 according to their latest regulatory filings, with 89 funds opening new positions, 385 increasing their positions, 386 reducing their positions, and 86 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.1% more ownership

Funds ownership: 88.06%89.16% (+1.1%)

3% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 86

0% less repeat investments, than reductions

Existing positions increased: 385 | Existing positions reduced: 386

1% less funds holding

Funds holding: 1,0681,059 (-9)

12% less capital invested

Capital invested by funds: $36.7B → $32.4B (-$4.33B)

16% less funds holding in top 10

Funds holding in top 10: 2521 (-4)

18% less call options, than puts

Call options by funds: $86.1M | Put options by funds: $105M

Holders
1,059
Holders Change
-9
Holders Change %
-0.84%
% of All Funds
16.81%
Holding in Top 10
21
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-16%
% of All Funds
0.33%
New
89
Increased
385
Reduced
386
Closed
86
Calls
$86.1M
Puts
$105M
Net Calls
-$18.9M
Net Calls Change
-$56M
Name Holding Trade Value Shares
Change
Change in
Stake
BFO
201
Boston Family Office
Massachusetts
$12M -$312K -625 -2%
PAI
202
Pittenger & Anderson Inc
Nebraska
$11.9M +$951K +1,908 +8%
GKIM
203
GW&K Investment Management
Massachusetts
$11.8M -$314K -630 -2%
WC
204
Woodstock Corp
Massachusetts
$11.8M -$89.3K -179 -0.7%
AWM
205
AE Wealth Management
Kansas
$11.7M +$280K +561 +2%
HPC
206
HM Payson & Co
Maine
$11.6M +$327K +655 +3%
GIP
207
Granite Investment Partners
California
$11.5M -$162K -325 -1%
MCM
208
Marsico Capital Management
Colorado
$11.5M -$2.24M -4,500 -15%
SLAM
209
Swiss Life Asset Management
$11.3M +$1.73M +3,470 +16%
Zurich Cantonal Bank
210
Zurich Cantonal Bank
Switzerland
$10.9M -$3.46M -6,944 -22%
Millennium Management
211
Millennium Management
New York
$10.9M -$7.61M -15,251 -38%
CCA
212
Cobblestone Capital Advisors
New York
$10.8M -$155K -311 -1%
CIC
213
Chilton Investment Company
Connecticut
$10.6M -$20.4K -41 -0.2%
SG Americas Securities
214
SG Americas Securities
New York
$10.6M +$3.3M +6,625 +38%
SMDAM
215
Sumitomo Mitsui DS Asset Management
Japan
$10.6M -$806K -1,617 -6%
MIM
216
MetLife Investment Management
New Jersey
$10.5M -$267K -536 -2%
KCM
217
Kornitzer Capital Management
Kansas
$10.3M
BST
218
Bath Savings Trust
Maine
$10.3M -$171K -343 -1%
ASRS
219
Arizona State Retirement System
Arizona
$10.3M -$111K -222 -0.9%
Commonwealth Equity Services
220
Commonwealth Equity Services
Massachusetts
$10.2M +$2.49K +5 +0%
NB
221
Norinchukin Bank
Japan
$10.2M -$962K -1,929 -8%
UAS
222
United Asset Strategies
New York
$10.1M -$155K -311 -1%
CIBC Asset Management
223
CIBC Asset Management
Ontario, Canada
$10.1M +$1.14M +2,284 +11%
PIM
224
Progressive Investment Management
Oregon
$10.1M -$125K -250 -1%
AAM
225
Ardevora Asset Management
United Kingdom
$10M -$8.75M -17,552 -43%

IDXX Hedge Fund Activity: Q3 2023 in Review

1,059 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q3 2023, worth a combined $32.4B — down 12% from $36.7B a quarter earlier.

Buyers outnumbered sellers: 89 funds opened new IDXX positions and 86 closed out — a net gain of 3 holders — while 385 added to existing stakes and 386 trimmed.

The largest buyer was GQG Partners, opening a new position worth an estimated $465M. The largest seller was AllianceBernstein, cutting an estimated $133M.

  • 1,059 institutional investors held Idexx Laboratories (IDXX) as of Q3 2023, down from 1,068 in Q2 2023.
  • Funds reported $32.4B of Idexx Laboratories stock for Q3 2023, down 12% quarter-over-quarter.
  • 89 funds opened new Idexx Laboratories positions in Q3 2023 and 86 closed out, a net change of +3 holders.
  • The largest Idexx Laboratories buyer in Q3 2023 was GQG Partners, an estimated $465M added.
  • The largest Idexx Laboratories seller in Q3 2023 was AllianceBernstein, an estimated $133M sold.

Based on aggregated 13F filings for Q3 2023.